*Muto, Y., *Moroishi, T., Ichihara, K., Nishiyama, M., Shimizu, H., Eguchi, H., Moriya, K., Koike, K., Mimori, K., Mori, M., Katayama, Y., and Nakayama, K.I.

Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis

J. Exp. Med. 216, 950-965 (2019). [*Equal contribution]

• Highlighted in J. Exp. Med. 216, 723-724 (2019)

Moroishi, T., Hayashi, T., Pan, W.W., Fujita, Y., Holt, M.V., Qin, J., Carson, D.A., and Guan, K.L.

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

Cell 167, 1525-1539 (2016).

• Highlighted in Dev. Cell 39, 635-637 (2016).
• Highlighted in Cancer Discov. 7, OF8 (2017).
• Highlighted in J. Thorac. Dis. 9, 1748-1751 (2017).
• 日本語による解説はコチラ

Moroishi, T., Park, H.W., Qin, B., Chen, Q., Meng, Z., Plouffe, S.W., Taniguchi, K., Yu, F.X., Karin, M., Pan, D., and Guan, K.L.

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis

Genes Dev. 29, 1271-1284 (2015).

*Moroishi, T., *Hansen, C.G., and Guan, K.L.

The emerging roles of YAP and TAZ in cancer

Nat. Rev. Cancer 15, 73-79 (2015). [*Equal contribution]

*Hansen, C.G., *Moroishi, T., and Guan, K.L.

YAP and TAZ: a nexus for Hippo signaling and beyond

Trends Cell Biol. 25, 499-513 (2015). [*Equal contribution]

Moroishi, T., Nishiyama, M., Takeda, Y., Iwai, K., and Nakayama, K.I.

The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo

Cell Metab. 14, 339-351 (2011).

• Highlighted in Cell Metab. 14, 281-282 (2011).
• 日本語による解説はコチラ